Human Keratinocytes Inhibit CD4


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
08 06 2021
Historique:
received: 10 05 2021
revised: 03 06 2021
accepted: 04 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 30 10 2021
Statut: epublish

Résumé

Human skin protects the body against infection and injury. This protection involves immune and epithelial cells, but their interactions remain largely unknown. Here, we show that cultured epidermal keratinocytes inhibit allogenic CD4

Identifiants

pubmed: 34201301
pii: cells10061438
doi: 10.3390/cells10061438
pmc: PMC8227977
pii:
doi:

Substances chimiques

TGFB1 protein, human 0
Transforming Growth Factor beta1 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CEA Funding, CEA PhD Program funding
ID : 2019-2021

Références

Nat Biomed Eng. 2019 Dec;3(12):985-997
pubmed: 31636412
Plast Reconstr Surg. 2004 Apr 15;113(5):1347-54
pubmed: 15060346
J Biomed Sci. 2015 Dec 02;22:107
pubmed: 26627200
J Immunol. 2010 May 1;184(9):4918-25
pubmed: 20363965
J Invest Dermatol. 2001 Sep;117(3):750-2
pubmed: 11564188
FASEB J. 2013 Sep;27(9):3643-51
pubmed: 23752205
Int J Cancer. 2003 Aug 20;106(2):232-5
pubmed: 12800199
Proc Natl Acad Sci U S A. 1999 May 11;96(10):5674-9
pubmed: 10318943
Trends Immunol. 2008 Mar;29(3):125-32
pubmed: 18249584
Blood. 2007 Dec 1;110(12):3936-48
pubmed: 17804694
Cell Mol Life Sci. 2011 Feb;68(3):397-404
pubmed: 21103908
Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11520-5
pubmed: 9326642
Am J Pathol. 2001 Jul;159(1):71-7
pubmed: 11438456
Exp Dermatol. 2010 Apr;19(4):387-92
pubmed: 20201955
Hum Immunol. 2016 Sep;77(9):711-9
pubmed: 27085792
Stem Cell Res. 2014 Sep;13(2):342-54
pubmed: 25218797
Immunol Today. 1995 Oct;16(10):487-94
pubmed: 7576053
Z Rheumatol. 2021 Feb;80(1):96-102
pubmed: 32274530
J Hematol Oncol. 2021 Jan 7;14(1):10
pubmed: 33413496
Burns. 2011 Sep;37(6):964-72
pubmed: 21550174
Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):385-93
pubmed: 12023143
Immunol Today. 1990 Jul;11(7):237-44
pubmed: 2201309
Annu Rev Immunol. 2008;26:677-704
pubmed: 18173375
Cancer Res. 1999 Apr 15;59(8):1954-60
pubmed: 10213506
Ann Surg. 1975 Sep;182(3):183-97
pubmed: 809014
Transplantation. 2017 Sep;101(9):2192-2199
pubmed: 27820781
Nature. 2017 Nov 16;551(7680):327-332
pubmed: 29144448
Immunol Rev. 2008 Aug;224:166-82
pubmed: 18759926
Sci Transl Med. 2020 Mar 11;12(534):
pubmed: 32161104
J Burn Care Res. 2010 Jul-Aug;31(4):559-68
pubmed: 20616650
Immunity. 2018 Mar 20;48(3):434-452
pubmed: 29562194
Adv Immunol. 2015;127:33-144
pubmed: 26073983
Hum Immunol. 2020 Apr;81(4):168-177
pubmed: 32081570
Semin Cancer Biol. 2007 Dec;17(6):480-4
pubmed: 17981049
Int Immunol. 2001 Mar;13(3):385-94
pubmed: 11222508
Lancet. 2000 Jun 17;355(9221):2138
pubmed: 10902633
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4510-5
pubmed: 9539768
Semin Plast Surg. 2019 Aug;33(3):162-166
pubmed: 31384231
J Invest Dermatol. 1998 Sep;111(3):497-502
pubmed: 9740247
Stem Cells Transl Med. 2015 Jun;4(6):643-54
pubmed: 25848122
Cytotherapy. 2014 May;16(5):631-9
pubmed: 24364910
Hum Immunol. 2004 Jan;65(1):39-46
pubmed: 14700594
J Immunol. 2014 Feb 15;192(4):1536-46
pubmed: 24453251
Eur J Immunol. 1994 Jan;24(1):176-80
pubmed: 8020553
Blood. 2004 Mar 1;103(5):1796-8
pubmed: 14592815
Genes Immun. 2013 Mar;14(2):115-26
pubmed: 23328844
J Hepatol. 2003 Oct;39(4):587-94
pubmed: 12971970
Autoimmun Rev. 2005 Jan;4(1):16-20
pubmed: 15652774
N Engl J Med. 1984 Aug 16;311(7):448-51
pubmed: 6379456
Cancer Immunol Res. 2019 Oct;7(10):1619-1632
pubmed: 31451484
Stem Cells Dev. 2016 Oct 1;25(19):1454-69
pubmed: 27465875
Am J Transplant. 2015 Feb;15(2):461-71
pubmed: 25488753
J Leukoc Biol. 2004 Dec;76(6):1220-8
pubmed: 15459235
Arthritis Res Ther. 2020 Mar 6;22(1):42
pubmed: 32143707
Clin Exp Dermatol. 2005 Jul;30(4):422-5
pubmed: 15953086
Proc Natl Acad Sci U S A. 1979 Nov;76(11):5665-8
pubmed: 293669
Cell Stem Cell. 2014 Jan 2;14(1):121-30
pubmed: 24388175
Sci Rep. 2018 Jan 25;8(1):1605
pubmed: 29371688

Auteurs

Guillaume Mestrallet (G)

CEA, Laboratory of Genomics and Radiobiology of Keratinopoiesis, Institute of Cellular and Molecular Radiobiology, Francois Jacob Institute of Biology, DRF, 91000 Evry, France.
Université Paris-Saclay, 91190 Saint-Aubin, France.

Frédéric Auvré (F)

CEA, Laboratory of Genomics and Radiobiology of Keratinopoiesis, Institute of Cellular and Molecular Radiobiology, Francois Jacob Institute of Biology, DRF, 91000 Evry, France.
Université Paris-Saclay, 91190 Saint-Aubin, France.

Chantal Schenowitz (C)

CEA, DRF, Francois Jacob Institute of Biology, Hemato-Immunology Research Department, Saint-Louis Hospital, 75010 Paris, France.
U976 HIPI Unit, IRSL, Université Paris, 75010 Paris, France.

Edgardo D Carosella (ED)

CEA, DRF, Francois Jacob Institute of Biology, Hemato-Immunology Research Department, Saint-Louis Hospital, 75010 Paris, France.
U976 HIPI Unit, IRSL, Université Paris, 75010 Paris, France.

Joel LeMaoult (J)

CEA, DRF, Francois Jacob Institute of Biology, Hemato-Immunology Research Department, Saint-Louis Hospital, 75010 Paris, France.
U976 HIPI Unit, IRSL, Université Paris, 75010 Paris, France.

Michèle T Martin (MT)

CEA, Laboratory of Genomics and Radiobiology of Keratinopoiesis, Institute of Cellular and Molecular Radiobiology, Francois Jacob Institute of Biology, DRF, 91000 Evry, France.
Université Paris-Saclay, 91190 Saint-Aubin, France.

Nathalie Rouas-Freiss (N)

CEA, DRF, Francois Jacob Institute of Biology, Hemato-Immunology Research Department, Saint-Louis Hospital, 75010 Paris, France.
U976 HIPI Unit, IRSL, Université Paris, 75010 Paris, France.

Nicolas O Fortunel (NO)

CEA, Laboratory of Genomics and Radiobiology of Keratinopoiesis, Institute of Cellular and Molecular Radiobiology, Francois Jacob Institute of Biology, DRF, 91000 Evry, France.
Université Paris-Saclay, 91190 Saint-Aubin, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH